About biopreservation Biopreservation is the process of preserving the functionality and integrity of cells, tissues, and organs outside the native environment for extended storage time at different temperatures. In the US, vaccines save 3 million lives annually but because of inadequate storage and improper refrigeration, vaccines worth $20 million are wasted annually. Vaccines are of two types: live and inactivated. Based on their sensitivity and types, these vaccines are stored at different temperature. For example, inactivated vaccines are sensitive to excessive heat and freezing temperature; therefore, they are stored at 2°C to 8°C. Live vaccines such as varicella and MMRV are stored at -15°C. Similar to vaccines, biological specimens such as blood, plasma, and tumor cell lines need to be stored to remain functional. Preservation of biological samples is important as these samples are used for clinical, research, and commercial purposes. The preservation of biosamples includes in-vitro culture, hypothermic storage, cryopreservation, and desiccation. The rising demand for storage has emerged the global biopreservation market. Based on storage temperature, the market can be... Research Beam Model: Research Beam Product ID: 329044 2500 USD New
Global Biopreservation Market 2015-2019
 
 

Global Biopreservation Market 2015-2019

  • Category : Materials and Chemicals
  • Published On : September   2015
  • Pages : 63
  • Publisher : Technavio
 
 
 
About biopreservation
Biopreservation is the process of preserving the functionality and integrity of cells, tissues, and organs outside the native environment for extended storage time at different temperatures. In the US, vaccines save 3 million lives annually but because of inadequate storage and improper refrigeration, vaccines worth $20 million are wasted annually. Vaccines are of two types: live and inactivated. Based on their sensitivity and types, these vaccines are stored at different temperature. For example, inactivated vaccines are sensitive to excessive heat and freezing temperature; therefore, they are stored at 2°C to 8°C. Live vaccines such as varicella and MMRV are stored at -15°C. Similar to vaccines, biological specimens such as blood, plasma, and tumor cell lines need to be stored to remain functional. Preservation of biological samples is important as these samples are used for clinical, research, and commercial purposes.

The preservation of biosamples includes in-vitro culture, hypothermic storage, cryopreservation, and desiccation. The rising demand for storage has emerged the global biopreservation market.

Based on storage temperature, the market can be classified into five categories:

Room temperature (+20°C)
Refrigeration (+4°C)
Frozen (-20°C)
Ultra-low (-80°C)
Cryogenic (-196°C)
Technavio's analysts forecast the global biopreservation market to grow at a CAGR of 17.06% over the period 2014-2019.

Covered in this report
This report covers the present and future scenario of the global biopreservation market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of biopreservation storage equipment, freezing media, and other cryoware accessories.

Technavio's report, Global Biopreservation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also covers the landscape of the market and its growth prospects in the coming years. The report includes a detailed discussion of the key vendors operating in this market.

Key regions

Americas
APAC
EMEA
Key vendors

BioCision
BioLife Solutions
Thermo Fisher Scientific
Other prominent vendor

Brooks Automation
Biomatrica
Chart MVE BioMedical
CRYO
Eppendorf North America
Haier Bio-Medical and Laboratory
Helmer Scientific
Panasonic Healthcare
So-Low Environmental Equipment
VWR Lab Products
Market driver

Growing demand for temperature-sensitive vaccines and biologicals
For a full, detailed list, view our report
Market Challenge

Reduced immunogenic potency of vaccines due to inappropriate storage conditions
For a full, detailed list, view our report
Market trend

Preserving human cells for regenerative medicines
For a full, detailed list, view our report
Key questions answered in this report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview
Biopreservation
Biopreservation methods
PART 06: Biobank funding and financial sustainability
Moving toward cost recovery model
PART 07: Harmonization of biobanking
PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 09: Market segmentation by application
Global biopreservation market for biobank
Global biopreservation market for regenerative medicine
Global biopreservation market for drug discovery
PART 10: Market segmentation by product
Capital equipment
Media
PART 11: Geographical segmentation
Biopreservation market in EMEA
Biopreservation market in Americas
Biopreservation market in APAC
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
Competitive Scenario
Market share analysis 2014
Other prominent vendors
PART 18: Key vendor analysis
BioCision
BioLife Solutions
Thermo Fisher Scientific
PART 19: Appendix
List of abbreviations
PART 20: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Different types of biopreservation methods
Exhibit 03: Revenue models of biobanks
Exhibit 04: Organizations and initiatives toward biobank harmonization
Exhibit 05: Global biopreservation market 2014-2019 ($ billions)
Exhibit 06: Five forces analysis
Exhibit 07: Segmentation of global biopreservation market by application
Exhibit 08: Segmentation of global biopreservation market by application 2014
Exhibit 09: Global biopreservation market for biobank 2014-2019 ($ billions)
Exhibit 10: Global biopreservation market for regenerative medicine 2014-2019 ($ millions)
Exhibit 11: Global biopreservation market for drug discovery 2014-2019 ($ millions)
Exhibit 12: Segmentation of global biopreservation market by product 2014
Exhibit 13: Segmentation of global biopreservation market by geography 2014
Exhibit 14: Biopreservation market in EMEA 2014-2019 ($ millions)
Exhibit 15: Biopreservation market in Americas 2014-2019 ($ millions)
Exhibit 16: Biopreservation market in APAC 2014-2019 ($ millions)
Exhibit 17: Cost-effectiveness of viable and functional cells with storage time and transportation
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: BioCision: Key takeaways
Exhibit 21: BioLife Solutions: Key takeaways
Exhibit 22: Thermo Fisher Scientific: Key takeaways
Exhibit 23: BioCision: Product segmentation
Exhibit 24: Business segmentation by revenue 2014
Exhibit 25: Business segmentation by revenue 2014
Exhibit 26: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 27: Geography segmentation by revenue 2014

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT